AXDX stock results show that Accelerate Diagnostics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
Articles
FDMT Stock Earnings: 4D Molecular Therapeutics Beats EPS for Q2 2024
FDMT stock results show that 4D Molecular Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. More
APTO Stock Earnings: Aptose Biosciences Beats EPS for Q2 2024
APTO stock results show that Aptose Biosciences beat analyst estimates for earnings per share the second quarter of 2024. More
CLDX Stock Earnings: Celldex Therapeutics Beats EPS, Beats Revenue for Q2 2024
CLDX stock results show that Celldex Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
DNTH Stock Earnings: Dianthus Therapeutics Beats EPS, Beats Revenue for Q2 2024
DNTH stock results show that Dianthus Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
GPCR Stock Earnings: Structure Therapeutics Beats EPS for Q2 2024
GPCR stock results show that Structure Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. More
FRD Stock Earnings: Friedman Industries Reported Results for Q1 2025
Friedman Industries just reported results for the first quarter of 2025. More
